Literature DB >> 25521365

Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.

Eduardo Vital de Carvalho1, Michele Emy Hukuda1, Renata Escorcio1, Mariana Callil Voos1, Fátima Aparecida Caromano1.   

Abstract

BACKGROUND AND
PURPOSE: The progression of Duchenne muscular dystrophy (DMD) results in the emergence of multiple and varied synergies to compensate muscle weakness and to deal with the demands of the functional tasks (e.g. gait). No functional evaluation instrument for individuals with DMD allows the detailed description (subjective qualitative evaluation) and compensatory movement scoring (objective quantitative evaluation) exclusively of gait. For this reason, clinicians and therapists face difficulties in assessment and decision-making of this functional activity. This study aimed to elaborate the gait domain of the Functional Evaluation Scale for DMD (FES-DMD-GD) and test its intra-rater and inter-rater reliabilities and its relationship with age and timed motor performance.
METHOD: We listed all the compensatory movements observed in 102 10-m gait videos of 51 children with DMD. Based on this report, the FES-DMD-GD was created and submitted to the review of 10 experts. After incorporating the experts suggestions, three examiners scored the videos using the FES-DMD-GD. The intra-rater and inter-rater reliabilities was calculated. Spearman correlation tests investigated the relationships between FES-DMD-GD and age and timed motor performance (p < 0.05).
RESULTS: The FES-DMD-GD was composed of three phases and had 14 items to quantify compensatory movements on gait. Intra-class correlation coefficients ranged from acceptable (0.74) to excellent (0.99). FES-DMD-GD correlated to age and timed motor performance.
CONCLUSION: This pilot version of FES-DMD-GD showed reliability and correlated to age and timed motor performance.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Duchenne muscular dystrophy; evaluation; gait; gait reliability; scales

Mesh:

Year:  2014        PMID: 25521365     DOI: 10.1002/pri.1605

Source DB:  PubMed          Journal:  Physiother Res Int        ISSN: 1358-2267


  4 in total

1.  β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy.

Authors:  Letizia Brogi; Maria Marchese; Alessandro Cellerino; Rosario Licitra; Valentina Naef; Serena Mero; Carlo Bibbiani; Baldassare Fronte
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

2.  Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

Authors:  David Israeli; Jérôme Poupiot; Fatima Amor; Karine Charton; William Lostal; Laurence Jeanson-Leh; Isabelle Richard
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

3.  Responsiveness of the domain climbing up and going down stairs of the Functional Evaluation scale for Duchenne Muscular Dystrophy: a one-year follow-up.

Authors:  Priscila S Albuquerque; Mariana C Voos; Mariene S Simões; Joyce Martini; Carlos B M Monteiro; Fatima A Caromano
Journal:  Braz J Phys Ther       Date:  2016-06-16       Impact factor: 3.377

4.  Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study.

Authors:  Pedro Labisa; Valeska Andreozzi; Melina Mota; Susana Monteiro; Rita Alves; João Almeida; Björn Vandewalle; Jorge Felix; Katharina Buesch; Hugo Canhão; Igor Beitia Ortiz de Zarate
Journal:  Pharmacoecon Open       Date:  2021-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.